Immunocore – First Site in Global Uveal Melanoma Patient Registry Now Open
Eleven centers to capture patient-reported outcomes about rare form of eye cancer
(OXFORD, England & CONSHOHOCKEN, Pa. & ROCKVILLE, Md. & ONTARIO, Canada, 4 March 2019) Immunocore Limited, a leading T cell receptor biotechnology company, and Pulse Infoframe Inc. (Pulse), with a platform healthie™ that supports patient registries, data aggregation and analytics, today announce that data collection for the first global patient registry in uveal melanoma (UM) has begun at Columbia University Irving Medical Center in New York. This effort is being co-led by Richard Carvajal, MD, from Columbia University Irving Medical Center and New York-Presbyterian Hospital, US, Joseph Sacco, MD, from the University of Liverpool, UK, and Anthony Joshua, MD, from The Kinghorn Cancer Centre, St Vincent’s Hospital Sydney, and the University of New South Wales, Australia. Ten additional centres across the US, UK and Australia are expected to open over the coming year.